Learn more

ETHYPHARM SA

Overview
  • Total Patents
    640
  • GoodIP Patent Rank
    56,154
  • Filing trend
    ⇩ 100.0%
About

ETHYPHARM SA has a total of 640 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1983. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and France. Its main competitors in its focus markets pharmaceuticals, machines and measurement are BELANOFF JOSEPH K, MEDICAL RES INST and BENTLEY PHARMACEUTICALS INC.

Patent filings per year

Chart showing ETHYPHARM SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Herry Catherine 149
#2 Oury Pascal 124
#3 Chenevier Philippe 65
#4 Suplie Pascal 58
#5 Marechal Dominique 55
#6 Debregeas Patrice 51
#7 Leduc Gerard 47
#8 Zuccarelli Jean-Marc 37
#9 Contamin Pauline 36
#10 Chauveau Charles 34

Latest patents

Publication Filing date Title
FR3099881A1 Low strength opioid orodispersible tablet and its preparation method.
US2015250737A1 Alcohol-resistant oral pharmaceutical form
FR3027802A1 DOUBLE MASKING TASTE ACTIVE PRINCIPLE GRANULES, PROCESS FOR THEIR PREPARATION AND ORODISPERSIBLE TABLETS CONTAINING SAME
FR3014692A1 ORAL PHARMACEUTICAL COMPOSITIONS WITH GASTRIC RETENTION.
FR2999432A1 ORODISPERSIBLE COMPRESSES OBTAINED BY COMPRESSION MOLDING
FR2999086A1 ORAL AND / OR ORAL COMPOSITION IN FINE FILM FORM OF A LOW SOLUBLE ACTIVE INGREDIENT, PROCESS FOR PREPARING THE SAME AND USE THEREOF
FR2991879A1 ORAL PHARMACEUTICAL FORMULATION OF CLASS III BCS MOLECULES
AU2012202717A1 Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
FR2983409A1 COMPRESSOR CAPABLE OF COMBATTING INJECTION MISTAKE
AU2011202580A1 Low-dose tablets having a network of polymers
FR2967066A1 SUBLINGUAL USE OF NON-COMPRESSED MICROGRANULES
FR2962331A1 PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION, METHOD USING THE SAME
FR2962550A1 METHOD FOR CONTROLLING CHEMICAL SUBMISSION, USE OF COLORING AGENT FOR COMBATING CHEMICAL SUBMISSION AND PHARMACEUTICAL COMPOSITION FOR THE IMPLEMENTATION OF THE METHOD
FR2960775A1 MICROGRANULES RESISTANT TO MISMATCH
FR2959935A1 ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM
FR2950253A1 LIPID NANOCAPSULES, PREPARATION METHOD AND USE AS MEDICAMENT
FR2946533A1 REDUCTION OF PLASMATIC FLUCTUATIONS OF OPIOIDS.
FR2943539A1 PHARMACEUTICAL COMPOSITION COMPRISING A IMMUNOSUPPRESSIVE MACROLIDE OF THE LIMUS FAMILY.
FR2940118A1 PHARMACEUTICAL FORMULATION OF NANONIZED FENOFIBRATE
FR2936709A1 ALCOHOL-RESISTANT TABLETS.